Company Data
Erasca Inc.
Ticker
ERAS
Current Price
$1.45 31.82%
Market Cap
$410.8M
Price Target
Refer to Report
Volume
3.9M
52wk Range
$1.01 - $3.45
Overview
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company’s pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers.